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BIDIRECTIONAL PROMOTERS AND 
METHODS RELATED THERETO 
FIELD OF THE INVENTION 
The vast majority of promoters in plants are 
unidirectional, With one upstream (5‘) promoter directing 
only one gene Which is 3‘ to the promoter. It is often 
desirable to introduce multiple genes into plants for meta 
bolic engineering, trait stacking and other purposes. It is also 
desirable to minimiZe repeated use of a single promoter, 
because repeated use may result in gene silencing. The 
present invention provides a strategy to make polar promot 
ers bidirectional so that one promoter can direct the expres 
sion of tWo genes. 
Common promoters are polar; that is, only one gene 
operably linked to a promoter can be expressed. In the 
present invention, in contrast, the inventors have found that 
a naturally-occurring unidirectional promoter can be bidi 
rectionaliZed by fusing a minimal promoter at its 5‘ end in an 
opposite orientation to the promoter (FIGS. 2 and 3), and 
that the engineered promoter can simultaneously direct the 
expression of tWo genes, With one gene on each end. 
BACKGROUND OF THE INVENTION 
Gene expression consists of tWo major consecutive pro 
cesses called transcription (from DNA to mRNA) and trans 
lation (from mRNA to protein/peptide). Transcription is 
often directed by a speci?c DNA sequence called a promoter 
that is in the upstream region of the transcribed DNA or 
gene. An eukaryotic promoter consists of tWo parts: one is 
called the core or minimal promoter, and the other comprises 
regulatory sequences or cis regulatory elements (FIG. 1). A 
minimal promoter is the DNA sequence that is immediately 
in the upstream of the transcription start site, and it generally 
contains a short sequence called the TATA box (FIG. 1). The 
role of a minimal promoter or TATA box is to provide a site 
for assembling the transcription initiation complex consist 
ing of RNA polymerase II, transcription factor II B (TFIIB), 
TFIID, TFIIE, and TFIIH. HoWever, the minimal promoter 
itself has no transcriptional activity. Its activation requires 
the cis regulatory elements on Which other speci?c tran 
scription factor(s) bind and subsequently interact With the 
transcription initiation complex to activate gene transcrip 
tion. The arrangement of cis regulatory elements-minimal 
promoter determines that a promoter must be polar or 
unidirectional. Almost all eukaryotic promoters are unidi 
rectional With one promoter directing one gene expression. 
An array of promoters have been cloned and Widely used 
for basic research and biotechnological applications. 
HoWever, it is often needed to introduce multiple genes into 
plants for metabolic engineering and other purposes. To 
minimiZe or avoid repeated use of a single promoter 
(therefore minimiZe the potential for gene silencing), several 
strategies have been developed, including sequential trans 
formation using multiple constructs With different selectable 
markers, co-transformation With multiple constructs, genetic 
crosses betWeen plants transformed With different 
constructs, and fusion of multiple peptides With a plant virus 
proteinase-based protein splicing mechanism. The present 
inventors have invented a method as described beloW by 
Which one can make one polar promoter bidirectional so that 
one promoter can be used to direct the expression of tWo 
genes, or gene fusions. 
A typical eukaryotic promoter consists of a minimal 
promoter and other upstream cis elements. LeWin, B. Gene 
VI (Oxford University Press, Oxford, 1997), Odell, J. T., 
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Nagy, F. & Chua, N.-H. Nature 313, 810—812 (1990), and 
Benfey, P. N. & Chua, N.-H. Science 250, 959—966 (1990). 
The minimal promoter is essentially a TATA box region 
Where RNA polymerase II binds to initiate transcription, but 
itself has no transcriptional activity Benfey, P. N. & Chua, 
N.-H. Science 250, 959—966 (1990). The cis elements, upon 
binding by speci?c transcriptional factors, individually or in 
combination, determine the spatio-temporal expression pat 
tern of a promoter. Benfey, P. N. & Chua, N.-H. Science 250, 
959—966 (1990). 
Arti?cial constructs as Well as exception to nature’s rule 
have been disclosed previous to the present invention. None 
have described a bidirectional promoter as is described 
herein. Representative patents are summariZed beloW. 
US. Pat. No. 5,814,618 discloses a bidirectional promoter 
Which has multiple tet operator sequences (de?ned in the 
speci?cation as enhancers or repressors) and ?anking mini 
mal promoters. US. Pat. No. 5,955,646 discloses bidirec 
tional heterologous constructs. US. Pat. No. 5,368,855 
discloses a naturally-occurring bidirectional promoter. US. 
Pat. No. 5,359,142 discloses constructs Which have been 
manipulated to permit variation in enhancement of gene 
expression. US. Pat. No. 5627046 discloses a naturally 
occurring bidirectional promoter. US. Pat. No. 5,827,693 
discloses modi?ed hemoglobin promoters. Signi?cant in this 
patent is column 12 of the background of the invention, 
Wherein a long list of promoters, some of Which are 
bidirectional, are disclosed. The yeast promoters disclosed 
are all naturally-occurring ones. 
Despite the existence of naturally-occurring bidirectional 
promoters, it Was not clear at the time of the present 
invention, that any unidirectional promoter can be bidirec 
tionaliZed. The US. Pat. No. 5,814,618 shoWed that seven 
repeats of the prokaryotic Tet repressor/operator/inducer 
sequences, When ?anked by tWo minimal promoters in the 
presence of tetracyclin inducer, could direct the expression 
of tWo genes in eukaryotic cells Where raltaed additional 
prokaryotic proteins/peptides Were also expressed. US. Pat. 
No. 5814618 did not teach hoW to make an eukaryotic polar 
promoter bidirectional, especially When the speci?c 
sequences of the cis elements in an eukaryotic promoter 
Were unknoWn. In contrast, the current invention describes 
a novel method by Which any eukaryotic polar promoter can 
be bidirectionaliZed even at the time When the speci?c cis 
elements on the promoter may be not necessarily identi?ed 
yet. There is ample art to shoW that stearic hindrance, and 
other physical as Well as chemical barriers makes promoter 
construction unpredictable. 
Citation of the above documents is not intended as an 
admission that any of the foregoing is pertinent prior art. All 
statements as to the date or representation as to the contents 
of these documents is based on subjective characteriZation 
of information available to the applicant, and does not 
constitute any admission as to the accuracy of the dates or 
contents of these documents. 
SUMMARY OF THE INVENTION 
In the present invention, the inventors have developed a 
strategy by Which a naturally-occurring unidirectional pro 
moter can be bidirectionaliZed by fusing a minimal promoter 
at its 5‘ end in an opposite orientation to the promoter (FIG. 
1), and that the engineered promoter can simultaneously 
direct the expression of tWo genes, With one gene on each 
end. 
The present invention comprises arti?cial nucleic acid 
constructs comprising a bidirectional promoter having mini 
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mal promoter and a common promoter, wherein said mini 
mal promoter is operably linked 5‘ to the common promoter, 
and in opposite orientation to said common promoter. Those 
arti?cial nucleic acid constructs, Wherein said bidirectional 
promoter further comprises at least one gene operably linked 
to said minimal promoters and said common promoter are 
preferred. In particular, those constructs Wherein said mini 
mal promoter is a minimal promoter of a promoter selected 
from the group consisting of cauli?ower mosaic virus 35S 
RNA promoter (herein 35S), peanut chloritic streak cauli 
movirus full-length transcript promoter (herein PClSV), the 
Arabidopsis 12-oxophytodienoic acid-10, ll-reductase gene 
promoter (herein OPR), and SAG12 are preferred. The 
common promoter may or may not be de?ned or knoWn 
although preferred are arti?cial nucleic acids comprising 
common promoter selected from the group consisting of 
cauli?oWer mosaic virus 35S RNA promoter (herein 35S), 
peanut chloritic streak caulimovirus full-length transcript 
promoter (herein PClSV), the Arabidopsis 
12-oxophytodienoic acid-10, ll-reductase gene promoter 
(herein OPR), and SAG12. 
In additional embodiments are arti?cial nucleic acid con 
structs Which comprise at least one gene and Wherein the 
gene is an agronomically-signi?cant gene. In those 
embodiments, it is preferred that said agronomically 
signi?cant gene is selected from the group consisting of: 
male sterility; self-incompatibility; foreign organism resis 
tance; improved biosynthetic pathWays; environmental tol 
erance; photosynthetic pathWays; and nutrient content and/ 
or fruit ripening; oil biosynthesis; pigment biosynthesis; 
seed formation; starch metabolism; salt tolerance; cold/frost 
tolerance; drought tolerance; tolerance to anaerobic condi 
tions; protein content; carbohydrate content (including sug 
ars and starches); amino acid content; and fatty acid content. 
Plants comprising the nucleic acid constructs are 
provided, including, preferably plants selected from the 
group consisting of: soybean; maiZe; sugar cane; beet; 
tobacco; Wheat; barley; poppy; rape; sun?oWer; alfalfa; 
sorghum; rose; carnation; gerbera; carrot; tomato; lettuce; 
chicory; pepper; melon; cabbage; oat; rye; cotton; ?ax; 
potato; pine; Walnut; citrus (including oranges, grapefruit 
etc.); hemp; oak; rice; petunia; orchids; Arabidopsis; broc 
coli; cauli?oWer; brussel sprouts; onion; garlic; leek; squash; 
pumpkin; celery; pea; bean (including various legumes); 
straWberries; grapes; apples; pears; peaches; banana; palm; 
cocoa; cucumber; pineapple; apricot; plum; sugar beet; laWn 
grasses; maple; triticale; saf?oWer; peanut; and olive. 
Plant parts comprising a nucleic acid constructs are also 
provided, particularly those selected from the group con 
sisting of cells, seeds, embryos, leaves, roots, and stems. 
The present invention also provides methods to transfer 
nucleic acid into a plant cell, comprising contacting a 
nucleic acid constructs of the present invention to at least 
one plant cell under conditions suf?cient to alloW said 
nucleic acid to enter said cell. In particular, there are 
provided methods to impart agronomically-signi?cant char 
acteristics to a plant, comprising contacting a nucleic acid 
constructs of the present invention to at least one plant cell 
under conditions suf?cient to alloW said nucleic acid to enter 
said cell. 
By “agronomically-signi?cant” it is meant any trait of a 
plant Which is recogniZed by members of the agricultural 
industry as desirable. 
“Common” or “unidirectional” or “polar” promoter 
means a naturally-occurring unidirectional promoter, or a 
unidirectional promoter Which is an obvious variation of a 
naturally-occurring unidirectional promoter. 
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“Operatively linked” the spatial relationship of tWo or 
more pieces of DNA such that the referent piece(s) is 
capable of effecting an intended genetic outcome of another 
referent sequence. The pieces may be joined together by 
recombinant DNA techniques, including, but not limited to, 
restriction enZyme digestion and ligations. 
By “plant” it is meant one or more plant seed, plant 
embryo, plant part or Whole plant. The plant may be an 
angiosperm (monocot or dicot), gymnosperm, man-made or 
naturally-occurring. 
By “proteins” it is meant any compounds Which comprise 
amino acids, including peptides, polypeptides, fusion 
proteins, etc. 
Moreover, for the purposes of the present invention, the 
term “a” or “an” entity refers to one or more of that entity; 
for example, “a protein” or “a nucleic acid molecule” refers 
to one or more of those compounds or at least one com 
pound. As such, the terms “a” (or “an”), “one or more” and 
“at least one” can be used interchangeably herein. It is also 
to be noted that the terms “comprising”, “including”, and 
“having” can be used interchangeably. Furthermore, a com 
pound “selected from the group consisting of” refers to one 
or more of the compounds in the list that folloWs, including 
mixtures (i.e., combinations) of tWo or more of the com 
pounds. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is an illustration of a typical eukaryotic gene 
promoter (common promoter) that consists of a minimal 
promoter and cis regulatory elements. The arroW indicates 
the transcription polarity. 
FIG. 2 is an illustration of the novel strategy for bidirec 
tionaliZing a typical eukaryotic gene promoter by fusing a 
minimal promoter at the 5‘ end of the promoter in opposite 
orientation. The minimal promoter can be the same as that 
of the common promoter (homogeneous) or derived from a 
different eukaryotic promoter (heterogenetic). 
FIG. 3 is a diagram of promoter bidirectionaliZation 
strategy and some constructs. Acommon promoter directing 
the gene 1 expression can be bipolariZed by fusing a minimal 
promoter at its 5‘ end in an opposite orientation so that it can 
also direct the gene 2 expression. 1 to 6 are different 
constructs in the pPZP211 vector. NPT II encodes an 
enZyme that renders a transgenic plant resistant to kanamy 
cin mini stands for minimal promoter. PClSV is the peanut 
chlorotic streak virus full-length transcript promoter. SAG 
mini is a minimal promoter derived from the senescence 
speci?c SAG12 promoter. OPRl is an inducible promoter. 
GUS ([3-glucuronidase) and GFP (green ?uorescent protein) 
are reporter genes. 
FIG. 4 are schematic maps of pGL429 (Where the bidi 
rectionaliZed CaMV 35S promoter directs the expression of 
the reporter gene GUS) and pGL489 (Where the common 
35S promoter controls the GUS expression. BamH I/Bgl II 
in pGL429 and Xba I/Spe I in pGL489 are tWo compatible 
restriction enZyme sites that are ligated. LB and RB are the 
left and right T-DNA border. Small arroWs indicate the 
transcriptional start site and polarity. 
FIG. 5 shoWs typical examples of GUS stainings in 
transgenic Arabidopsis thaliana (ecotype gll) seedlings (25 
day old) transformed With (A) pGL429 or (B) pGL489. 
FIG. 6 shoWs the GUS expression levels in randomly 
selected 105 T1 Arabidopsis seedlings (excluding roots) 
transformed With pGL429 (Q) or pGL489 The back 
ground value for 4 nontransgenic Wild-type plants is also 
presented 
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DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention comprises arti?cial nucleic acid 
constructs comprising a bidirectional promoter having mini 
mal promoter and a common promoter, Wherein said mini 
mal promoter is operably linked 5‘ to the common promoter, 
and in opposite orientation to said common promoter. Those 
arti?cial nucleic acid constructs, Wherein said bidirectional 
promoter further comprises at least one gene operably linked 
to said minimal promoters and said common promoter are 
preferred. In particular, those constructs Wherein said mini 
mal promoter is a minimal promoter of a promoter selected 
from the group consisting of cauli?ower mosaic virus 35S 
RNA promoter (35S), peanut chloritic streak caulimovirus 
full-length transcript promoter (PClSV), the Arabidopsis 
12-oxophytodienoic acid-10, ll-reductase gene promoter 
(OPR), and SAG12 are preferred. The common promoter 
may or may not be fully de?ned scienti?cally (may be 
identi?ed, but not fully characterized). Preferred are arti? 
cial nucleic acids comprising common promoter selected 
from the group consisting of cauli?oWer mosaic virus 35S 
RNA promoter (35S), peanut chloritic streak caulimovirus 
full-length transcript promoter (PClSV), the Arabidopsis 
12-oxophytodienoic acid-10, ll-reductase gene promoter 
(OPR), and SAG12. 
In additional embodiments are arti?cial nucleic acid con 
structs Which comprise at least one gene and Wherein the 
gene is an agronomically-signi?cant gene. In those 
embodiments, it is preferred that said agronomically 
signi?cant gene is selected from the group consisting of: 
male sterility; self-incompatibility; foreign organism resis 
tance; improved biosynthetic pathWays; environmental tol 
erance; photosynthetic pathWays; and nutrient content and/ 
or fruit ripening; oil biosynthesis; pigment biosynthesis; 
seed formation; starch metabolism; salt tolerance; cold/frost 
tolerance; drought tolerance; tolerance to anaerobic condi 
tions; protein content; carbohydrate content (including sug 
ars and starches); amino acid content; and fatty acid content. 
Plants comprising the present constructs are provided, 
including, preferably plants selected from the group con 
sisting of: soybean; maiZe; sugar cane; beet; tobacco; Wheat; 
barley; poppy; rape; sun?oWer; alfalfa; sorghum; rose; car 
nation; gerbera; carrot; tomato; lettuce; chicory; pepper; 
melon; cabbage; oat; rye; cotton; ?ax; potato; pine; Walnut; 
citrus (including oranges, grapefruit etc.); hemp; oak; rice; 
petunia; orchids; Arabidopsis; broccoli; cauli?oWer; brussel 
sprouts; onion; garlic; leek; squash; pumpkin; celery; pea; 
bean (including various legumes); straWberries; grapes; 
apples; pears; peaches; banana; palm; cocoa; cucumber; 
pineapple; apricot; plum; sugar beet; laWn grasses; maple; 
triticale; safflower; peanut; and olive. 
Plant parts comprising a constructs of the present inven 
tion are also provided, particularly those selected from the 
group consisting of cells, seeds, embryos, leaves, roots, and 
stems. 
The present invention also provides methods to transfer 
nucleic acid into a plant cell, comprising contacting a 
nucleic acid constructs of the present invention to at least 
one plant cell under conditions suf?cient to alloW said 
nucleic acid to enter said cell. In particular, there are 
provided methods to impart agronomically-signi?cant char 
acteristics to a plant, comprising contacting a nucleic acid 
constructs of the present invention to at least one plant cell 
under conditions suf?cient to alloW said nucleic acid to enter 
said cell. 
The present invention also comprises a method of bidi 
rectionaliZing promoters so that one promoter can be used to 
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direct the expression of tWo genes. Brie?y, the method 
involves fusing a minimal promoter (essentially a TATA 
box-like region) to the 5‘ end of a regular promoter in an 
opposite direction; then tWo genes of interest With appro 
priate 3‘ terminators can be fused to the ends of the recon 
structed promoter, With one gene on each end. 
In one embodiment is a method that involves fusing a 
minimal promoter at the 5‘ end of a promoter (FIG. 2). The 
orientation of the minimal promoter is opposite to the 
regular promoter. The recombinant promoter then becomes 
bidirectional. After genes of interest are operably linked to 
the recombinant promoter With one gene at each end of the 
recombinant promoter (FIG. 2), the construct Will direct the 
expression of both genes simultaneously in transgenic plant 
cells. 
The inventors made various constructs (FIG. 3) and 
demonstrated that the constitutive promoters such as cauli 
?oWer mosaic virus (CaMV) 35S promoter or peanut chlo 
rotic streak caulimovirus (PClSV) full-length transcript 
(FLt) promoter, upon being bidirectionaliZed (constructs 
1—4 in FIG. 3), can ef?ciently direct the expression of tWo 
genes that have been fused at the respective ends of the 
engineered promoter regardless the source of the minimal 
promoter. The constitutive expression pattern of both genes 
appears to be similar (if not identical) to each other. FIG. 5A 
shoWs a typical GUS expression pattern directed by the 35S 
minimal promoter-bidirectionaliZed 35S promoter compared 
With (in 5B) the expression pattern directed by the common 
35S promoter. The expression level of each gene from the 
bidirectional promoter appears to be comparable to that from 
unidirectional promoter. The GUS expression levels directed 
by the 35S minimal promoter-bidirectionaliZed 35S pro 
moter in 100 out of 105 randomly selected transgeneic 
Arabidopsis seedlings are indeed even higher than those 
directed by the 35S promoter (FIG. 6). There Were four 
plants in Which 35S promoter-directed GUS expression Was 
higher than that directed by bidirectionaliZed promoter (FIG. 
6 insert). This could result from the position effect because 
the 35S promoter directing the GUS expression in pGL489 
Was adjacent to the right border of T-DNA. HoWever, there 
is essentially no expression of the second gene if a second 
minimal promoter is not present (PGL 440 in FIG. 3); the 
fusion of a minimal promoter at the 5‘ end of a promoter 
makes the promoter become bidirectional. The bidirection 
aliZed promoters are heritable in the ?rst three generations 
so far tested. 
As mentioned above, a minimal promoter is essential for 
bidirectionaliZing a promoter. The minimal promoter could 
be derived from the promoter that Was to be bidirectional 
iZed (e.g., the constitutive expression cauli?oWer mosaic 
virus or CaMV 35S promoter and its minimal promoter in 
pGL429). The minimal promoter could also be derived from 
other promoters than the promoter that Was to be 
bidirectionaliZed, e. g., the minimal promoter in pGL483 Was 
derived from the peanut chlorotic streak virus or PClSV 
promoter (a constitutive expression promoter), and the mini 
mal promoter in pGL471 Was derived from the SAG12 
promoter (a senescence-speci?c promoter). The minimal 
promoter is essentially a TATA box region Where the RNA 
polymerase II and other factors bind to initiate transcription 
in eukaryotes). The minimal promoter itself has no tran 
scriptional activity. As expected, the different minimal pro 
moters used here just functioned the same; all of them 
bidirectionaliZed the 35S promoter. The effectiveness of the 
heterologous source of minimal promoter Was also demon 
strated in pGL482 and pGL479, in Which the 35S minimal 
promoter Was able to bidirectionaliZe the PClSV promoter (a 
US 6,388,170 B1 
7 
constitutive expression promoter) and the 12-oxo 
phytodienoic acid reductase (OPR1) promoter, respectively. 
The OPR1 promoter is a jasmonate-, Wound-, and 
senescence-inducible promoter, thus demonstrating that 
inducible promoters can also be bidirectionaliZed, in addi 
tion to the constitutive 35S and PClSV promoters. 
The number of base pairs betWeen the minimal promoters 
and the regular promoters in the examples are as folloWs, 
although the number of base pairs betWeen the minimal 
promoter and common promoter is not as important as the 
need to be operably linked: 
pGL429: 261bp (—51 of the 35S minimal promoter to 
~746 of the 35S promoter) (SEQ ID NO. 9); these are 
pPZP211 vector sequences. 
pGL482: 30bp (—51 of the 35S minimal promoter to 5‘ end 
of the PClSV promoter) (SEQ ID NO. 9); these are pPZP211 
vector multiple cloning site sequences. 
pGL483: 240bp (5‘ end of the PClSV minimal promoter 
to ~746 of the 35S promoter) (SEQ ID NO. 10); these are 
pPZP211 vector sequences. 
pGL471: 277bp (-469 of the SAG12 minimal promoter to 
~746 of the 35S promoter) (SEQ ID NO. 11); these are 
pPZP211 vector sequences. 
pGL479: 12bp (—51 of the 35S minimal promoter to ~246 
of the OPR1 promoter) (SEQ ID NO.12); these are pPZP211 
vector sequences. 
pGL440: 267bp (from the translation start codon ATG of 
the GUS ORF to ~746 of the 35S promoter); these are 
pPZP211 vector sequences. 
The TATA box region and cis elements of the 35S 
promoter have been described (Benfey, P. N. & Chua, N.-H. 
Science 250, 959—966 (1990). The PClSV promoter has also 
been described (Maiti, I. B. & Shepherd, R. J. Biochem 
Biophys Res Commu 244,440—44 (1998). The SAG12 mini 
mal promoter Was found no transcriptional activity (Gan, S. 
& Amasino, R. M. Science 270, 1986—1988 (1995). The 
OPR1 promoter sequence Was also reported. (Biesgen, C. & 
Weiler, E. W. Planta 208, 155—165 (1999). 
The inventors ?rst tested the Widely used cauli?oWer 
mosaic virus 35S promoter. The 35S minimal promoter (—51 
to transcription start point), When fused at the 5‘ end of the 
regular 35S promoter (—746 to start point), Was able to 
constitutively direct the reporter gene ([3-glucuronidase 
(GUS) expression in all 150 independent transgenic Arabi 
dopsis lines that Were resistant to kanamycin (50 pg ml_1) 
conferred by the 35S promoter directed NPT II gene 
(pGL429 in FIG. 3) (FIG. 5). The GUS expression level in 
each line varies (FIG. 6). The minimal promoter is necessary 
for bidirectionaliZing the promoter because transgenic Ara 
bidopsis plants harboring a similar construct Without the 
minimal promoter (pGL440 in FIG. 3) did not shoW GUS 
expression. 
The inventors then investigated if a heterogenetic minimal 
promoter can also bipolariZe the 35S promoter. When the 
minimal promoters derived from the peanut chlorotic streak 
virus (PClSV) promoter or from the senescence-speci?c 
SAG12 promoter replaced the 35S minimal promoter in 
pGL429 to form pGL483 and pGL471, respectively, trans 
genic plants harboring these constructs (47 and 22 indepen 
dent plants for respective constructs) all shoWed constitutive 
GUS expression. 
The ability of this bidirectionaliZation strategy Was also 
demonstrated using another constitutive expression 
promoter, the PClSV promoter. The 364 base pairs PClSV 
promoter Was used to direct the NPT II for kanamycin 
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resistance in transgenic plants. When a 35S minimal 
promoter-GUS-mas terminator Was fused at the 5‘ end of the 
promoter (pGL482 in FIG. 3), the PClSV promoter Was able 
to direct the GUS expression in all 29 kanamycin-resistant 
Arabidopsis plants. 
In addition to the constitutive 35S and PClSV promoters, 
the inventors found that the OPR1 promoter, an inducible 
promoter by Wounding, jasmonate and senescence, Was 
bidirectionaliZed by the 35S minimal promoter (pGL479 in 
FIG. 3) in all 8 lines of transgenic Arabidopsis plants We 
obtained. Both the GUS and the green ?uorescent protein 
(GFP) expression Was detected in senescing leaves and 
induced by Wounding and jasmonate treatment in young 
leaves. 
The heritability and stability of the bidirectionaliZed pro 
moters Was examined in randomly selected 10 independent 
Arabidopsis lines transformed With pGL429. All progeny 
(the second and third generations) of these lines that Were 
resistant to kanamycin shoWed constitutive GUS expression. 
Vectors Which comprise the above constructs are Within 
the scope of the present invention, as are plants transformed 
With the above constructs. Vectors may be obtained from 
various commercial sources, including Clontech 
Laboratories, Inc. (Palo Alto, Calif.), Stratagene (La Jolla, 
Calif.), Invitrogen (Carlsbad, Calif.), NeW England Biolabs 
(Beverly, Mass.) and Promega (Madison, Wis.). Preferred 
vectors are those binary vectors Which are capable of trans 
ferring the sequences disclosed herein into plant cells or 
plant parts. Examples of the binary vectors the inventors 
used are those pPZP100s and pPZP200s series vectors 
(HajdukieWiscZ, P., Svab,Z. & Maliga, P. (1994) The small, 
versatile pPZP family of Agrobacterium binary vectors for 
plant transformation. Plant Molecular Biology 25: 
989—994). 
Recombinant DNA technologies can be used to improve 
expression of transformed nucleic acid molecules by 
manipulating, for example, the number of copies of the 
nucleic acid molecules Within a host cell, the efficiency With 
Which those nucleic acid molecules are transcribed, the 
ef?ciency With Which the resultant transcripts are translated, 
and the ef?ciency of post-translational modi?cations. 
Recombinant techniques useful for increasing the expres 
sion of nucleic acid molecules of the present invention 
include, but are not limited to, operatively linking nucleic 
acid molecules to high-copy number plasmids, integration of 
the nucleic acid molecules into one or more host cell 
chromosomes, addition of vector stability sequences to 
plasmids, substitutions or modi?cations of transcription 
control signals (e.g., promoters, operators, enhancers), sub 
stitutions or modi?cations of translational control signals 
(e.g., ribosome binding sites, Shine-Dalgarno sequences), 
modi?cation of nucleic acid molecules of the present inven 
tion to correspond to the codon usage of the host cell, 
deletion of sequences that destabiliZe transcripts, and use of 
control signals that temporally separate recombinant cell 
groWth from recombinant enZyme production during fer 
mentation. The activity of an expressed recombinant protein 
may be improved by fragmenting, modifying, or derivatiZ 
ing nucleic acid molecules encoding such a protein. 
Constructs of the present invention may be transferred to 
cells according to the methods of the present invention, as 
Well as using any of the folloWing Well- knoWn means: 
infective, vector-containing bacterial strains (such as Agro 
bacterium rhiZogenes and Agrobacterium tumefaciens) 
according to eg Zambryski, 43 Ann. Rev. Pl . Physiol. Pl. 
Mol Biol 465 (1992); pollen-tube transformation [Zhon-xun 
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et al., 6 Plant Molec. Bio. 165 (1988)]; direct transformation 
of germinating seeds [Toepfer et al., 1 Plant Cell 133 
(1989)]; polyethylene glycol or electroporation transforma 
tion [Christou et al., 84 Proc. Nat. Acad. Sci 3662 (1987)]; 
and biolistic processes [Yang & Christou, Particle Bombard 
ment Technology for Gene Transfer (1994)]. 
The transformed cells may be induced to form trans 
formed plants via organogenesis or embryogenesis, accord 
ing to the procedures of Dixon Plant Cell Culture: A Prac 
tical Approach (IRL Press, Oxford 1987). 
EXAMPLES 
Reactions and manipulations involving DNA techniques, 
unless stated otherWise, Were performed as described in 
Sambrook et al., 1989, Molecular Cloning: A Laboratory 
Manual, Cold Spring Harbor Laboratory Press. 
Constructs 
Standard DNA manipulation (restriction digestion, plas 
mid isolation, cloning, etc.) Was performed as described in 
Sambrook, J ., E. F. Fritsch, et al. (1989). Molecular Cloning: 
A Laboratory Manual. NeW York, Cold Spring Harbor 
Laboratory Press. 
pGL429: the CaMV 35S minimal promoter (—51 region) 
With the TMV RNA (leader sequence Was PCR-ampli?ed 
using pSH9 (Holtorf, S., K. Apel, et al. (1995). Comparison 
of different constitutive and inducible promoters for the 
overexpression of transgenes in Arabidopsis thaliana. Plant 
Mol. Biol. 29: 637—646) as the template With tWo primers 
(5‘GAAGATCTGATATCAAGCTTCGCAAGACCC3‘ 
(SEQ ID NO:1) and 5‘GGAATTCCATGGATCCCGGGTG 
TAATTGTAAATAG3‘ (SEQ ID NO:2)). The omega leader 
sequence can enhance gene expression at the posttranscrip 
tional level (Gallie, D. R., D. E. Sleat, et a1. (1987). The 
5‘-leader sequence of tobacco mosaic virus RNA enhances 
the expression of foreign gene transcripts in vitro and in 
vivo. Nucleic Acids Res 15: 3257—3273). The PCR product, 
upon cut With Bgl II and EcoR I, Was cloned into pLIT 
MUS28 (NeW England Biolab, Mass., USA) to form 
pGL400. A GUS-MAS terminator from pSG506 (Gan, S. 
(1995). Molecular characteriZation and genetic manipula 
tion of plant senescence. Department of Biochemistry. 
Madison, University of Wisconsin-Madison: 190) Was then 
cloned into pGL400 at the Nco I and Xba I sites to form the 
35S minimal promoter-GUS-MAS terminator (pGL407), 
Which Was subsequently cloned into the binary vector 
pPZP211 at the BamH I and Xba I sites to form pGL429. 
The 35S promoter (—419 region)-NPT II Was part of the 
pPZP211 sequence (HajdukieWicZ, R, Z. Svab, et al. (1994). 
The small, versatile pPZP family of Agrobacterium binary 
vectors for plant transformation. Plant Mol Biol 25: 
989—994). 
pGL482: the 364 base pairs of peanut chlorotic streak 
caulimovirus (PClSV) full length transcript promoter (Maiti, 
I. B. and R. J. Shepherd (1998). Isolation and expression 
analysis of peanut chlorotic streak caulimovirus (PClSV) 
full-length transcript (FLt) promoter in transgenic plants. 
Biochemical and Biophysical Research Communications 
244: 440—444.) Was cloned into pPZP211 at the EcoR I and 
Nco I sites to form pGL455. The 35S minimal promoter 
GUS-MAS terminator of pGL407 Was then subcloned into 
pGL455 to form pGL482. 
pGL483: the 117 base pairs of the PClSV minimal pro 
moter Was generated by PCR using a pair of primers 
(5‘GGAAGATCTGAATTCGTGCATCCGCTTTGC3‘ 
(SEQ ID NO:3) and 5‘CCCGGGATCCATGGAAACATAT 
TACAAGACTCG3‘ (SEQ ID NO:4)), Which Was fused With 
the GUS-MAS terminator of pSG506 (Gan 1995). The 
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PClSV minimal promoter-GUS-MAS terminator Was then 
cloned into the binary vector pPZP211 at the BamH I and 
Xba I sites. 
pGL471: using pSG499 (Gan 1995) as the template, the 
SAG12 minimal promoter Was PCR-cloned With the folloW 
ing pair of primers: 5‘ACTAGTAGATCTTACGTACTA 
CAAGAAAAATAAACATGTACG3‘ (SEQ ID NO:5) and 
5‘CCCGGGATCCATGGTGGAAG 
TATTTGAAAGAAAATTAAAAATAAAAAGGAAAG 
TTAAATGACTTTTGCTC3‘ (SEQ ID NO:6). The second 
primer contained the 34 bases of AMV RNA4 leader 
sequence that Will enhance expression at the posttranscrip 
tional level (Jobling, S. A. and L. Gehrke (1987). Enhanced 
translation of chimeric messenger RNAs containing a plant 
viral untranslated leader sequence. Nature 325: 622—625.). 
This minimal promoter contains 469 bp from the transcrip 
tion start site, 100 bp of the SAG12 5 ‘UTR sequence and the 
34 bp of AMV RNA4 leader sequence. This minimal pro 
moter Was fused With the GUS-MAS terminator (pGL467), 
Which Was subsequently cloned into pPZP211 at the XbaI 
site, resulting in tWo types of plasmid depending on the 
orientation of the SAG12 minimal promoter-GUS-MAS 
terminator relative to the 35S promoter-NPT II on the vector. 
The one With an opposite orientation Was named pGL471. 
pGL479: in an effort to identify genes that are upregulated 
during leaf senescence and inducible by jasmonate using 
enhancer trap strategy in Arabidopsis, the inventors cloned 
a gene, OPR1, that encodes the 12-oxophytodienoic acid 
reductase. In addition to senescence and jasmonate, this 
gene is inducible by Wounding (Biesgen, C. and E. W. 
Weiler (1999). Structure and regulation of OPR1 and OPR2, 
tWo closely related genes encoding 12-oxophytodienoic 
acid-10,11-reductases from Arabidopsis thaliana. Planta 
208: 155—165.). A PCR technique is employed to clone the 
promoter region of the promoter (310 bp) With the Arabi 
dopsis (ecotype Columbia) genomic DNA as the template 
and the folloWing pair of primers: 5‘TTCCATGGCTTTTG 
TAAAAAACTGTTG3‘ (SEQ ID NO:7) and 5‘GGAC 
TA G T G AATATATATATAT T C A G AT C TA G - 
GAAGGAACAAAGAAAG3‘ (SEQ ID NO:8). These 
primers introduced an Nco I site at the 3‘ end of the promoter 
and a Bgl II site at the 5‘ end. The PCR-ampli?ed promoter 
Was fused With the GUS-MAS terminator to form OPR1 
GUS-MAS terminator chimeric gene in pGL332. The 35S 
minimal promoter (—51 region)-GFP-NOS terminator Was 
PCR-ampli?ed using psmGFP (Davis, S. J. and R. D. 
Vierstra (1998). Soluble, highly ?uorescent variants of green 
?uorescent protein (GFP) for use in higher plants. Plant Mol. 
Biol. 36: 521—528.) as the template With the folloWing tWo 
primers: one is the M13 reverse primer and the other is 
5 ‘ GAAGATCTGATATCAAG CTTCGCAAGACCC3‘. The 
PCR product Was digested With both EcoR I and EcoR V, 
and subsequently cloned into pPZP211 at the EcoR I and 
Sma I sites to form pGL474. Finally, the OPR1-GUS-MAS 
terminator chimeric gene Was released from pGL332 using 
the restriction enZymes Bgl II and Xba I, and subcloned into 
pGL474 at the BamH I and Xba I sites to form pGL479. 
pGL440 Was derived from a plasmid called pGL418 
(similar With pGL429) by removing the 35S minimal pro 
moter. 
pGL489: the 35S promoter plus the omega sequence Was 
released from pSH9 (Holtorf, S., Apel, K. and Bohlmann, H. 
(1995) Comparison of different constitutive and inducible 
promoter for the overexpression of transgenes in Arabidop 
sis thaliana. Plant Mol Biol 29: 637—646) With the restriction 
enZymes Hind III and Nco I, and then subcloned into 
pGL407 at the same restriction sites to form the chimeric 
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gene 35S-GUS-MAS-ter in pGL488. This chimeric gene 
Was released from pGL488 With restriction enzymes Spe I 
and Xba I, and subsequently cloned into the binary vector 
pPZP211 at the Xba I site, resulting tWo plasmids, the one 
shoWn in FIG. 4 Was designated pGL489. 
Agrobacterium transformation 
The above constructs Were transferred into Agrobacte 
rium tumerfaciens strain ABI) using the freeZe-thaW method 
(An, G. (1987). Binary Ti vectors for plant transformation 
and promoter analysis. Methods in EnZymology: Recombi 
nant DNA. R. Wu and L. Grossman. San Diego, Academic 
Press. 153: 292—305.). Brie?y, about 2—5 pg of each of the 
DNA constructs Was added to a 1.5-ml microcentrifuge tube 
containing 100 pl of competent ABI cells, upon mixed, the 
mixer Was frozen in dry ice-ethanol bath, then placed in 37° 
C. Water bath for 5 minutes. 100 pl of YEP media Was added 
into the tube, and the Whole cells in the tube Were plated on 
the YEP plate containing 100 pig/L spectinomycin (YEP: 10 
g/L Bacto-peptone, 10 g/L Bacto-yeast extracts, 5 g NaCl; 
for plates, add 10 g/L phytoagar). 
Plant transformation and cultivation 
The Agrobacterium ABI cells containing the various 
constructs Were used to transform Arabidopsis (ecotype 
Columbia) via vacuum in?ltration (Bechtold, N., J. Ellis, et 
al. (1993). In Planta Agrobacterium-mediated gene transfer 
by in?ltration of adult Arabidopsis plants. C. R. Acad. Sci. 
Paris 316: 1194—1199.). Brie?y, about 200 mL YEP medium 
With 100 pig/L spectinomycin Was inoculated With 10 mL of 
preculture of Agrobacterium harboring the respective con 
struct. The cells of overnight culture (28° C., 250 RPM 
shaker) With ~1.4 OD600 Was pelletted by centrifugation 
and resuspended in 200 mL of in?ltration medium (l/zx 
Murashige-Skoog salts, 1>< B5 vitamins, 5% sucrose, 0.5 g 
MES, 0.044 pM benZylaminopurine and 0.02% SilWet L-77, 
pH 5.7). The resuspension Was transferred into a 250 mL 
beaker, and a pot of Arabidopsis plants that had several 
?oWers Was invertedly submerged in the cell suspension and 
vacuumed for 10—15 min using an air vacuum pump. The 
plants Were alloWed to complete their life cycle and the 
seeds Were harvested. After surface-steriliZed With 70% 
ethanol containing 0.1—0.2% Triton X-100, the seeds Were 
soWn on MS plates containing kanamycin (50 mg/L) and 
incubated 23° C. in an Arabidopsis groWth chamber With 
65% relative humidity under ~150 pmol m_2s_1 continuous 
light from a mixture of cool White ?uorescent (60%) and 
incandescent (40%) bulbs. The transgenic seedlings Were 
either assayed for GUS expression or transplanted into soil. 
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The plants Were groWn in a plant groWth facility under the 
conditions similar to those de?ned previously. 
Tobacco (Nicotiana tabacum cv. Wisconsin38 or W38) 
transformation Was performed using the standard 
Agrobacterium-mediated tissue culture method as described 
(Horsch, R. B. et al., (1985) Asimple and general method for 
transferring genes into plants. Science 227:1229—1231). 
Transgenic tobacco plants Were groWn in a greenhouse at 
23—25° C. under 16/8 light/dark cycle With 60% relative 
humidity. 
GUS EnZyme Assays 
The GUS assays in transgenic plants Were performed 
histochemically and quantitatively according to the standard 
protocol (Jefferson, R. A. (1987). Assaying chimeric genes 
in plants: the GUS gene fusion system. Plant Mol Biol Rep 
5: 387—405 X-glucuronide Was used as substrate for 
histochemical staining, and 4-methylumbelliferyl-[3-D 
gucuronide for quantitative assays. 
GFP Expression Induced by J asmonate, Wounding and 
Senescence 
For the jasmonate induction treatment, young, nonsenes 
cent leaves of pGL479 transgenic Arabidopsis plants Were 
?oated on 3 mM 2-[N-morpholino]-ethanesulfonic acid 
(MES) buffer (pH5 .8) containing 30 pM (—)-j asmonic acid 
(naturally occurring form from Sigma) for 1—3 hours. For 
controls, nontransgenic leaves that Were subject to the same 
treatment. 
For Wounding treatment, the young, nonsenescent leaves 
Were Wounded by pinching using a pair of forceps. 
The above treated leaves and leaves at senescence stage 3 
(about 50% distal part of a leaf turned yelloW but the rest 
Was still green) Were examined for GFP expression using a 
NikonTE200 microscope. The soluble modi?ed green ?uo 
rescent protein, smGFP, has a maximum excitation Wave 
length of 397 nm and an emission Wavelength of 507 nm 
(Davis, S. J. and R. D. Vierstra (1998). Soluble, highly 
?uorescent variants of green ?uorescent protein (GFP) for 
use in higher plants. Plant Mol. Biol. 36: 521—528.). After 
the ?uorescence microscope detection of GFP, the samples 
Were examined histochemically for GUS expression as 
described above. 
Although the present invention has been fully described 
herein, it is to be noted that various changes and modi?ca 
tions are apparent to those skilled in the art. Such changes 
and modi?cations are to be understood as included Within 
the scope of the present invention as de?ned by the 
appended claims. 
SEQUENCE LISTING 
<l60> NUMBER OF SEQ ID NOS: l2 
<2 10> SEQ ID NO 1 
<2ll> LENGTH: 30 
<2 12> TYPE: DNA 
<2 13> ORGANISM: synthetic construct 
<400> SEQUENCE: l 
gaagatctga tatcaagctt cgcaagaccc 
SEQ ID NO 2 
LENGTH: 35 
TYPE: DNA 
ORGANISM: synthetic construct 
30 
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SEQUENCE: 2 
ggaattccat ggatcccggg tgtaattgta aatag 
SEQ ID NO 3 
LENGTH: 30 
TYPE: DNA 
ORGANISM: synthetic construct 
SEQUENCE: 3 
ggaagatctg aattcgtgca tccgctttgc 
SEQ ID NO 4 
LENGTH: 33 
TYPE: DNA 
ORGANISM: synthetic construct 
SEQUENCE: 4 
cccgggatcc atggaaacat attacaagac tcg 
SEQ ID NO 5 
LENGTH: 42 
TYPE: DNA 
ORGANISM: synthetic construct 
SEQUENCE: 5 
actagtagat cttacgtact acaagaaaaa taaacatgta cg 
SEQ ID NO 6 
LENGTH: 70 
TYPE: DNA 
ORGANISM: synthetic construct 
SEQUENCE: 6 
cccgggatcc atggtggaag tatttgaaag aaaattaaaa ataaaaagga aagttaaatg 
acttttgctc 
SEQ ID NO 7 
LENGTH: 27 
TYPE: DNA 
ORGANISM: synthetic construct 
SEQUENCE: 7 
ttccatggct tttgtaaaaa actgttg 
SEQ ID NO 8 
LENGTH: 48 
TYPE: DNA 
ORGANISM: synthetic construct 
SEQUENCE: 8 
ggactagtga atatatatat attcagatct aggaaggaac aaagaaag 
SEQ ID NO 9 
LENGTH: 157 
TYPE: DNA 
ORGANISM: synthetic construct 
SEQUENCE: 9 
agatctgata tcaagcttcg caagaccctt cctctatata aggaagttca tttcatttgg 
agaggacagg cttcttgaga tccttcaaca attaccaaca acaacaaaca acaaacaaca 
35 
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ttacaattac tatttacaat acacccggga tccatgg 
<210> SEQ ID NO 10 
<2ll> LENGTH: 134 
<2 12> TYPE: DNA 
<213> ORGANISM: synthetic construct 
<400> SEQUENCE: l0 
gaattcgata tcgtgcatcc gctttgccta taaataagtt ttagtttgta ttgatcgaca 
cgatcgagaa gacacggcca tttggacgat catttgagag tctaaaagaa cgagtcttgt 
aatatgtttc catg 
<210> SEQ ID NO 11 
<2ll> LENGTH: 613 
<2 12> TYPE: DNA 
<213> ORGANISM: synthetic construct 
<400> SEQUENCE: ll 
agatcttacg 
tatttttttc 
aaatgctttc 
atcatcaaca 
ttactagata 
ccactaaaat 
tgtaggacta 
tgtagtcatt 
ttagcaatta 
aatcaaatta 
acttccacca 
tactacaaga 
caaataattt 
ttaaatatta 
catatccaac 
caaacttcct 
taactaaaaa 
aaatggctac 
acttgtaaaa 
catcaacctt 
agagcaaaag 
tgg 
<210> SEQ ID NO 12 
<2ll> LENGTH: 317 
<2 12> TYPE: DNA 
aaaataaaca 
atactcatga 
attttaatta 
ttcgaaaatc 
aatcatcaat 
tccgagcaaa 
gtatcaaaca 
caaaaatgct 
attttcacta 
tcatttaact 
tgtacgtaac 
tagatttttt 
attaaataag 
tctatagtac 
tataaatgtt 
gtgagtgaac 
tcaacgatca 
ttgatttgga 
taaaacccca 
ttccttttta 
<213> ORGANISM: synthetic construct 
<400> SEQUENCE: l2 
agatctagga 
atgtcgtcaa 
ggaggtccac 
ccttcctaaa 
tccacaattc 
ttttacaaaa 
aggaacaaag 
tgaatacgtc 
acatacgtcg 
ttctctgatc 
agggaaaatc 
gccatgg 
aaaggaatat 
atcatgaaga 
tcaatgacga 
aatcaatgtg 
ttcaaagtgt 
aggttaagtt 
aataaataat 
ccacgtccct 
tataaatatg 
ttgcagagaa 
tacgtatcag catgtaaaag 
ttttttgaaa tgtcaattaa 
gaaatatatt tatgcaaaac 
acaagtagag aaaataaatt 
tacaaaacta attaaaccca 
aagacttgat ttcaggttga 
tttagttatg tatgaatgaa 
tcaatcactt catgtgaaca 
tctcagtacc cttctgaagt 
tttttaattt tctttcaaat 
caaagtggtt aagctctcta 
ttccaagtgg atggacttgg 
taaggcgaaa taaacacttg 
cgcagatata tccattatcc 
atctaaattc atcaacagtt 
157 
60 
120 
134 
60 
120 
180 
240 
300 
360 
420 
480 
540 
600 
613 
60 
120 
180 
240 
300 
317 
What is claimed is: 
1. An arti?cial nucleic acid construct, comprising a bidi 
rectional promoter having a minimal promoter and a com- 60 
mon promoter, each end of the bidirectional promoter oper 
ably linked to a polynucleotide coding for a polypeptide, 
(a) Wherein said minimal promoter is operably linked to 
said common promoter, in opposite orientation to said 
common promoter, and 5‘ to said common promoter; 65 
(b) Wherein said bidirectional promoter further comprises 
a bidirectional promoter feature selected from the 
group consisting of said minimal promoter, and said 
common promoter; 
(b) Wherein said minimal promoter is a minimal promoter 
of a promoter selected from the group consisting of 
35S, PClSV OPR, and SAG12; and 
(c) Wherein said common promoter is selected from the 
group consisting of 35S, PCISV, OPR, and SAG12. 
2. The arti?cial nucleic acid construct of claim 1, Wherein 
said polynucleotide codes for an agronomically-signi?cant 
polypeptide. 
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3. The arti?cial nucleic acid construct of claim 2, wherein 
said polypeptide functions in a metabolic pathWay selected 
from the group consisting of male sterility; self 
incompatibility; foreign organism resistance; improved bio 
synthetic pathWays; environmental tolerance; photosyn 
thetic pathWays; and nutrient content. 
4. The arti?cial nucleic acid construct of claim 2, Wherein 
said polypeptide functions in a metabolic pathWay selected 
from the group consisting of fruit ripening; oil biosynthesis; 
pigment biosynthesis, seed formation; starch metabolism; 
salt tolerance, cold/frost tolerance; drought tolerance; toler 
ance to anaerobic conditions; protein content; carbohydrate 
content (including sugars and starches); amino acid content; 
and fatty acid content. 
5. Aplant comprising a nucleic acid construct of claim 1. 
6. The plant of claim 5, Wherein said plant is selected from 
the group consisting of: soybean; maiZe; sugar cane; beet; 
tobacco; Wheat; barley; poppy; rape; sun?oWer, alfalfa; 
sorghum; rose; carnation; gerbera; carrot; tomato; lettuce; 
chicory; pepper, melon; cabbage; oat; rye; cotton; ?aX; 
potato; pine; Walnut; citrus (including oranges, grapefruit 
etc.); hemp; oak; rice; petunia; orchids; Arabidopsis; broc 
coli; cauli?ower, brussel sprouts; onion; garlic; leek; squash; 
pumpkin celery; pea; bean (including various legumes); 
straWberries; grapes; apples; pears; peaches; banana; palm; 
cocoa; cucumber, pineapple; apricot; plum; sugar beet; laWn 
grasses, maple; triticale saf?oWer, peanut; and olive. 
7. A plant part comprising a nucleic acid construct of 
claim 1. 
8. The plant part of claim 7, Wherein said plant part is 
selected from the group consisting of cells, seeds, embryos, 
leaves, roots, and stems. 
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9. A method to transfer nucleic acid into a plant cell, 
comprising contacting a nucleic acid construct of claim 1 to 
at least one plant cell under conditions suf?cient to alloW 
said nucleic acid to enter said cell. 
10. A method to impart agronomically-signi?cant char 
acteristics to a plant, comprising contacting a nucleic acid 
construct of claim 1 to at least one plant cell under condi 
tions suf?cient to alloW said nucleic acid to enter said cell. 
11. A method of making a bidirectional promoter for use 
in plants, comprising 
(1) obtaining a polynucleotide comprising a plant 
promoter, Wherein the plant promoter comprises a 
Common promoter region selected from the group 
consisting 35S, PCISV, OPR and SAG 12; 
(2) linking a minimal promoter, selected from the group 
consisting of 35S, PCISV, OPR and SAG12, and the 
common promoter to provide a recombinant 
polynucleotide, such that the recombinant polynucle 
otide comprises the common promoter operably linked 
With the minimal promoter, Wherein 
(a) the minimal promoter is in opposite orientation to 
said common promoter, and; 
(b) the minimal promoter is 5‘ to said common pro 
moter. 
12. The method of claim 11, Wherein said bidirectional 
promoter further comprises a ?rst gene operably linked to 
said minimal promoter and a second gene operably linked to 
said common promoter, and Wherein said ?rst and second 
genes are optionally the same gene. 
